2. Signaling Pathways
  3. Immunology/Inflammation
  4. CD28
  5. CD28 Chemical

CD28 Chemical

CD28 Chemical (1):

Cat. No. Product Name Effect Purity
  • HY-P1698B
    Reltecimod TFA
    		Chemical 99.78%
    Reltecimod (AB-103) TFA is a T-cell-specific surface glycoprotein CD28 (TP44) antagonist. Reltecimod TFA has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod TFA modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod TFA can be used to research necrotizing soft-tissue infections (NSTIs).